Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2016

May 12, 2016

30643_dirs_2016-05-11_503f857b-8967-4ac9-831f-498196553fda.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-10

Reporting Person: Kogod Dennis (Pres, HCP & CEO, DVA Int.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-10 Common Stock M 56250 $55.34 Acquired 92716 Direct
2016-05-10 Common Stock F 40938 $76.04 Disposed 51778 Direct
2016-05-10 Common Stock S 15312 $76.25 Disposed 36466 Direct
2016-05-10 Common Stock M 110000 $58.94 Acquired 146466 Direct
2016-05-10 Common Stock F 85264 $76.04 Disposed 61202 Direct
2016-05-10 Common Stock S 24736 $76.25 Disposed 36466 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-10 Stock Appreciation Rights $55.34 M 56250 Disposed 2017-12-18 Common Stock (56250) Direct
2016-05-10 Stock Appreciation Rights $58.94 M 110000 Disposed 2018-03-19 Common Stock (110000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 84350 Indirect

Footnotes

F1: The Stock Appreciation Rights were granted on 12/18/2012. 50% vested on 4/1/2015 and the remaining 50% vested on 4/1/2016.

F2: The Stock Appreciation Rights were granted on 3/19/2013. 50% vested on 3/19/2016 and the remaining 50% will vest on 3/19/2017.